Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

3-D Super resolution Ultrasound Real time imaging of Erythrocytes

Project description

Super-resolution ultrasound imaging of erythrocytes

The goal of the EU-funded SURE project is to develop and research a super-resolution 3D ultrasound imaging method capable of visualising capillary flow in the human body. The approach will track the motion of the individual erythrocytes for the full visualisation of anatomy, flow and perfusion. The 3D super-resolution imaging is performed without any contrast agents and is 2 600 times faster than current methods. The method will achieve an isotropic resolution of 50 micrometers in all directions, and the volumetric resolution will be 100–400 times better than current state-of-the-art 3D ultrasound imaging. The research will be concluded by the clinical trials conducted on rodents and human subjects to study the changes in perfusion for diabetes and cancer.

Objective

"The SURE project: ""Super resolution Ultrasound Real time imaging of Erythrocytes"" will develop and research a new super resolution ultrasound imaging method capable of resolving capillary flow in the human body. The approach tracks the motion of the individual red blood cells (erythrocytes) in a three-dimensional volume for a full visualization of anatomy, flow, and perfusion in a volume down to 13 cm at 20 volumes per second. The super resolution imaging is performed without using contrast agents and is thereby 2600 times faster than current methods. The method has an isotropic resolution of 50 micrometer in all directions, and the volumetric resolution is thereby 100-400 times better than current state-of-the-art 3-D ultrasound imaging. These highly ambitious goals are attained in a synergistic research effort combing four research groups. The scientific project includes breakthroughs in silicon row-column probes with 1 million elements, advanced synthetic aperture ultrafast coded imaging, deep learning for detecting and tracking of cells, pressure gradient estimation, and visualization and quantification of several hundreds of Gbytes volumetric data. The research finally leads to clinical trials conducted on rodents and humans for studying the changes in perfusion for diabetes and cancer. The SURE imaging approach can yield a paradigm shift in the scientific study, diagnoses, and treatment of cancer, diabetes, and vascular disease at the capillary level, as it enables the possibility of volumetric visualizing capillary perfusion in real-time at frame rates above 20 Hz without injection of contrast agents. Imaging is performed using ultrasound at normal diagnostic levels with no known adverse effects and can, thus, be used on a wide range of the population from newborns to the elderly for both diagnosis and repeated screening."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-SyG - Synergy grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2019-SyG

See all projects funded under this call

Host institution

DANMARKS TEKNISKE UNIVERSITET
Net EU contribution
€ 7 384 019,00
Address
ANKER ENGELUNDS VEJ 101
2800 Kongens Lyngby
Denmark
Region
Danmark Hovedstaden Københavns omegn
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 7 384 019,00

Beneficiaries (3)